Greenleaf Trust’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Sell
6,685
-694
-9% -$45.6K ﹤0.01% 562
2026
Q1
$525K Buy
7,379
+1,200
+19% +$94.6K 0.01% 478
2025
Q4
$507K Sell
6,179
-206
-3% -$16.1K ﹤0.01% 496
2025
Q3
$480K Buy
6,385
+91
+1% +$6.79K ﹤0.01% 507
2025
Q2
$466K Sell
6,294
-2,070
-25% -$144K ﹤0.01% 505
2025
Q1
$675K Buy
8,364
+796
+11% +$68.4K 0.01% 419
2024
Q4
$592K Sell
7,568
-51
-0.7% -$4.33K 0.01% 470
2024
Q3
$715K Buy
7,619
+124
+2% +$10.4K 0.01% 429
2024
Q2
$584K Buy
7,495
+527
+8% +$43K 0.01% 440
2024
Q1
$633K Buy
6,968
+446
+7% +$37.1K 0.01% 411
2023
Q4
$504K Buy
6,522
+611
+10% +$42.8K 0.01% 459
2023
Q3
$402K Sell
5,911
-101
-2% -$7.35K ﹤0.01% 505
2023
Q2
$488K Sell
6,012
-504
-8% -$40.2K 0.01% 457
2023
Q1
$535K Buy
+6,516
New +$465K 0.01% 434

Other funds holding GEHC

Greenleaf Trust's GEHC Position: Q2 2026 in Review

Greenleaf Trust reduced its GE HealthCare (GEHC) stake by 9.4% in Q2 2026, selling an estimated $45.6K and leaving 6,685 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Greenleaf Trust first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $715K in Q3 2024. 239 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Greenleaf Trust held 6,685 shares of GE HealthCare worth $428K as of Q2 2026.
  • Greenleaf Trust sold 694 GE HealthCare shares in Q2 2026, an estimated $45.6K.
  • GE HealthCare made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #562 holding.
  • Greenleaf Trust first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Greenleaf Trust's GE HealthCare position peaked at $715K in Q3 2024.
  • 239 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.